Co-Authors
This is a "connection" page, showing publications co-authored by Tali-Anne Szwebel and Xavier Mariette.
Connection Strength
0.089
-
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. Eur J Cancer. 2017 09; 82:34-44.
Score: 0.045
-
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy. Ann Rheum Dis. 2018 03; 77(3):468-470.
Score: 0.044